The Biomedical Zone, a medical technology incubator and joint Ryerson University – St. Michael’s Hospital venture, has launched a medical device and software co-development lab.
The Biomedical Zone focuses on innovation driven by real-life clinical need. Front liners (i.e. doctors, nurses, and allied health professionals) are best positioned to identify problems and gaps. The Biomedical Zone’s Co-Development Lab gives students the opportunity to hone their engineering skills through relevant work experience, while clinicians are able to access the intellectual and technical resources within the Ryerson student body.
Students who wish for hands-on, practical experience and direct interaction with clinicians have the opportunity to co-develop solutions to real-life problems. St. Mike’s clinicians are given the opportunity to advance important, practical (non-research) projects. These opportunities would give doctors the chance to identify and progress high-impact, needs-based projects with biomedical applications,while assisting in the growth of young developers and engineers.
How it works
There is an online application and an in-person interview to assess fit (see below).
Motivated Ryerson students apply to the co-development lab through the website. Selected students are informed of the project, meet with the clinician (via interview), and if there is a good fit, co-develop a solution with the mentorship of the clinician.
For further inquiries please contact Nabil Uddin, Biomedical Startup Liason
Note: Co-Development Lab is not a research program. It is dedicated to needs-based innovation and experiential learning to develop real-world solutions.
Applications have now closed. Selected students will be contacted for an interview. Thank you for applying and your interest in the program.
Intellectual Property (IP) Policy : IP will be owned by SMH for the duration of the 8-month project. If, after project completion, students and clinicians (the Inventors) wish to commercialize the product, they will disclose to SMH and inventors will apply to Biomedical Zone. IP will be assigned to the co-inventors, following the SMH pre-existing agreement. If they are accepted, the co-inventors will fall under the inventor-owned IP clause of the Biomedical Zone’s entrepreneurial stream.